Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04765059
Title A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC) (COMPEL)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-squamous non-small cell carcinoma

Therapies

Cisplatin + Pemetrexed Disodium

Cisplatin + Osimertinib + Pemetrexed Disodium

Carboplatin + Osimertinib + Pemetrexed Disodium

Carboplatin + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA | ITA | ESP | DEU | AUT

Facility Status City State Zip Country Details
Research Site Recruiting Silver Spring Maryland 20910 United States Details
Research Site Recruiting Boston Massachusetts 02114 United States Details
Research Site Recruiting Boston Massachusetts 02215 United States Details
Research Site Recruiting Minneapolis Minnesota 55407 United States Details
Research Site Recruiting Graz 8036 Austria Details
Research Site Recruiting Klagenfurt 9020 Austria Details
Research Site Recruiting Linz 4020 Austria Details
Research Site Not yet recruiting Beijing 100005 China Details
Research Site Not yet recruiting Beijing 100142 China Details
Research Site Not yet recruiting Hohhot 010017 China Details
Research Site Not yet recruiting Shenyang 110001 China Details
Research Site Not yet recruiting Tianjin 300060 China Details
Research Site Not yet recruiting Zhengzhou City 450008 China Details
Research Site Recruiting Berlin 12351 Germany Details
Research Site Recruiting Hannover 30625 Germany Details
Research Site Recruiting Hessen 61231 Germany Details
Research Site Recruiting Karlsruhe 76137 Germany Details
Research Site Not yet recruiting Köln 50937 Germany Details
Research Site Not yet recruiting Köln 51109 Germany Details
Research Site Recruiting München D-80336 Germany Details
Research Site Not yet recruiting Ulm 89081 Germany Details
Research Site Recruiting Beer Sheva 84101 Israel Details
Research Site Recruiting Jerusalem 9103102 Israel Details
Research Site Recruiting Jerusalem 9112001 Israel Details
Research Site Recruiting Kfar Saba 4428164 Israel Details
Research Site Recruiting Petah Tikva 494142 Israel Details
Research Site Recruiting Tel Aviv 6423906 Israel Details
Research Site Recruiting Tel Hashomer 52621 Israel Details
Research Site Recruiting Firenze 50134 Italy Details
Research Site Not yet recruiting Meldola 47014 Italy Details
Research Site Not yet recruiting Messina 98158 Italy Details
Research Site Recruiting Napoli 80131 Italy Details
Research Site Recruiting Padova 35128 Italy Details
Research Site Not yet recruiting Palermo 90146 Italy Details
Research Site Recruiting Roma 00168 Italy Details
Research Site Recruiting Terni 05100 Italy Details
Research Site Recruiting Verona 37124 Italy Details
Research Site Recruiting Alicante 03010 Spain Details
Research Site Recruiting León 24071 Spain Details
Research Site Recruiting Madrid 28040 Spain Details
Research Site Recruiting Oviedo 33011 Spain Details
Research Site Recruiting Palma de Mallorca 07010 Spain Details
Research Site Recruiting Sevilla 41013 Spain Details
Research Site Recruiting Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field